These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 12138404)
1. Vascular endothelial growth factor in breast cancer: biologic and therapeutic aspects. Sledge GW Semin Oncol; 2002 Jun; 29(3 Suppl 11):104-10. PubMed ID: 12138404 [TBL] [Abstract][Full Text] [Related]
2. Clinical development of angiogenesis inhibitors to vascular endothelial growth factor and its receptors as cancer therapeutics. Zhu Z; Bohlen P; Witte L Curr Cancer Drug Targets; 2002 Jun; 2(2):135-56. PubMed ID: 12188915 [TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor in human colon cancer: biology and therapeutic implications. Ellis LM; Takahashi Y; Liu W; Shaheen RM Oncologist; 2000; 5 Suppl 1():11-5. PubMed ID: 10804085 [TBL] [Abstract][Full Text] [Related]
8. Angiogenesis-research frontiers. A basic science conference of the New York Academy of Medicine. Sepp-Lorenzino L; Pan BS Expert Opin Investig Drugs; 2000 Apr; 9(4):929-35. PubMed ID: 11185425 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of tumor growth and metastasis by targeting tumor-associated angiogenesis with antagonists to the receptors of vascular endothelial growth factor. Zhu Z; Witte L Invest New Drugs; 1999; 17(3):195-212. PubMed ID: 10665474 [TBL] [Abstract][Full Text] [Related]
12. The role of vascular endothelial growth factor (VEGF) in AIDS-related Kaposi's sarcoma. Arastéh K; Hannah A Oncologist; 2000; 5 Suppl 1():28-31. PubMed ID: 10804088 [TBL] [Abstract][Full Text] [Related]
13. Measuring VEGF-Flk-1 activity and consequences of VEGF-Flk-1 targeting in vivo using intravital microscopy: clinical applications. Vajkoczy P; Thurnher A; Hirth KP; Schilling L; Schmiedek P; Ullrich A; Menger MD Oncologist; 2000; 5 Suppl 1():16-9. PubMed ID: 10804086 [TBL] [Abstract][Full Text] [Related]
14. ZD6474 inhibits vascular endothelial growth factor signaling, angiogenesis, and tumor growth following oral administration. Wedge SR; Ogilvie DJ; Dukes M; Kendrew J; Chester R; Jackson JA; Boffey SJ; Valentine PJ; Curwen JO; Musgrove HL; Graham GA; Hughes GD; Thomas AP; Stokes ES; Curry B; Richmond GH; Wadsworth PF; Bigley AL; Hennequin LF Cancer Res; 2002 Aug; 62(16):4645-55. PubMed ID: 12183421 [TBL] [Abstract][Full Text] [Related]
15. [New molecular target of cancer therapy--angiogenesis regulator VEGF]. Toi M; Ueno T; Tominaga T Gan To Kagaku Ryoho; 1997 Dec; 24(15):2202-6. PubMed ID: 9422062 [TBL] [Abstract][Full Text] [Related]
16. Symposium on molecular pathogenesis of respiratory diseases and its clinical implication. 4. Molecular pathogenesis of lung cancer and its molecular targeted therapy. Sone S; Shinohara T; Nishioka Y; Yano S Intern Med; 2001 Feb; 40(2):167-70. PubMed ID: 11300157 [No Abstract] [Full Text] [Related]
17. Targeting vascular endothelial growth factor (VEGF) for anti-tumor therapy, by anti-VEGF neutralizing monoclonal antibodies or by VEGF receptor tyrosine-kinase inhibitors. Schlaeppi JM; Wood JM Cancer Metastasis Rev; 1999; 18(4):473-81. PubMed ID: 10855790 [TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor (VEGF) and its effect on angiogenesis. Jośko J; Gwóźdź B; Jedrzejowska-Szypułka H; Hendryk S Med Sci Monit; 2000; 6(5):1047-52. PubMed ID: 11208453 [TBL] [Abstract][Full Text] [Related]
19. Anti-angiogenic treatment strategies for malignant brain tumors. Kirsch M; Schackert G; Black PM J Neurooncol; 2000; 50(1-2):149-63. PubMed ID: 11245274 [TBL] [Abstract][Full Text] [Related]
20. Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: therapeutic implications. Ferrara N Semin Oncol; 2002 Dec; 29(6 Suppl 16):10-4. PubMed ID: 12516033 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]